Pricing
  1. US-listed companies
  2. Bionik Laboratories Corp.
  3. Financials
  4. Stockholders' equity

Bionik Laboratories Corp. (BNKL)

Market cap
$12.48
P/E ratio
SummaryFinancials
Period EndStockholders' equity (Million USD)YoY (%)
Mar 31, 2023-2-156.05%
Mar 31, 20223-10.78%
Mar 31, 20213-75.36%
Mar 31, 202013-51.41%
Mar 31, 201927+33.94%
Mar 31, 201820-11.76%
Mar 31, 201723+2271.31%
Dec 31, 20151-2586.12%
Dec 31, 2014-0-742.46%
Dec 31, 20110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat